Literature DB >> 9412084

[Chronic peritoneal dialysis as home therapy in childhood--risks and complications].

E Kitzmüller1, C Aufricht, G Mürwald, T Müller, E Balzar.   

Abstract

BACKGROUND: The aim of our study was to ascertain the complications of chronic peritoneal home dialysis in childhood. PATIENTS: 17 children were treated by ambulatory peritoneal home dialysis between 1984 and 1994 at the paediatric dialysis unit of the University Children's Hospital in Vienna, Austria. Their average age was 6.5 years (1 week to 12 years); 7 (41.2%) children were below school age (< 6 years).
RESULTS: In our observation period of 369 dialysis months (DM), the average duration of dialysis was 21.7 months (4.0-74.3). In relation to total DM the incidence of peritonitis was 1:23.1 of exit site infection 1:14.8 and of catheter related complications 1:41.0. 5 children developed hernias. 5 children were switched to haemodialysis and 8 children received kidney transplants. 2 children died from non-dialysis-associated causes.
CONCLUSION: Peritoneal dialysis, in contrast to haemodialysis, is a home treatment modality applicable even to infants. The most common complication is infection. Our data and the European and North American literature show that by close ambulatory monitoring and special hygenic procedures peritonitis frequency can be markedly reduced.

Entities:  

Mesh:

Year:  1997        PMID: 9412084

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  2 in total

1.  Risk factors for peritonitis in pediatric peritoneal dialysis: a single-center study.

Authors:  Michael Boehm; Andreas Vécsei; Christoph Aufricht; Thomas Mueller; Dagmar Csaicsich; Klaus Arbeiter
Journal:  Pediatr Nephrol       Date:  2005-08-05       Impact factor: 3.714

2.  [Chronic peritoneal dialysis in children. Results of the Vienna Pediatric Dialysis Department].

Authors:  Klaus Arbeiter; Andreas Vécsei; Thomas Mueller; Constanze Sanz; Egon Balzar; Christoph Aufricht
Journal:  Wien Klin Wochenschr       Date:  2003-09-30       Impact factor: 1.704

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.